Method Pharmaceuticals, LLC
NDC labeler code: 58657
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Haloperidol12 products
- Captopril8 products
- BaclofenGablofen, Lyvispah, Baclofen (Intrathecal) · 6 products
- Metolazone6 products
- LabetalolLabetalol HCL in Dextrose · 6 products
- MetronidazoleMetronidazole Vaginal, Metronidazole Vaginal Gel, Likmez · 4 products
- CarvedilolCoreg, Coreg CR · 4 products
- ClonidineClonidine Transdermal System, Catapres-Tts-1, Clonidine Transdermal System Usp, 0.1 Mg/Day · 3 products
- PhenylephrineBiorphen, Immphentiv · 3 products
- GabapentinNeurontin, Gralise, Relgaabi · 3 products
- Pyridostigmine bromideMestinon, Pryidostigmine Bromide, Regonol · 2 products
- CiprofloxacinCiprofloxacin in Dextrose, Cipro, Ciloxan · 2 products
- Metformin hydrochlorideGlumetza · 2 products
- Folic acidQuiofic · 1 product
- LevetiracetamKeppra, Spritam, Keppra XR · 1 product
- Cyproheptadine1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| March 14, 2024 | ANDA218412 | Phenylephrine PHENYLEPHRINE HYDROCHLORIDE | Hainan Poly |
| March 30, 2021 | ANDA213827 | Metolazone METOLAZONE | Innogenix |
| October 9, 2020 | ANDA212378 | Baclofen BACLOFEN | Andas 5 Holding |
| March 8, 2019 | ANDA211064 | Folic acid FOLIC ACID | Rising |
| October 16, 2018 | ANDA209108 | Cyproheptadine CYPROHEPTADINE HYDROCHLORIDE | Pharmazone |
| July 20, 2018 | ANDA211181 | Pyridostigmine bromide PYRIDOSTIGMINE BROMIDE | Mlv |
| June 22, 2018 | ANDA208921 | Ciprofloxacin CIPROFLOXACIN HYDROCHLORIDE | Pharmobedient |
| March 20, 2018 | ANDA209781 | Levetiracetam LEVETIRACETAM | Hainan Poly Pharm |
| February 18, 2016 | ANDA204989 | Gabapentin RELGAABI | Sciegen Pharms |
| September 11, 2013 | ANDA203769 | Metformin hydrochloride METFORMIN HYDROCHLORIDE | Sciegen Pharms |
| June 13, 2013 | ANDA202297 | Clonidine CLONIDINE HYDROCHLORIDE | Yung Shin Pharm |
| December 22, 2009 | ANDA078786 | Carvedilol CARVEDILOL | Mlv |
| July 29, 1999 | ANDA075215 | Labetalol LABETALOL HYDROCHLORIDE | Innogenix |
| May 30, 1997 | ANDA074677 | Captopril CAPTOPRIL | Andas 5 Holding |
| January 7, 1988 | ANDA071173 | Haloperidol HALOPERIDOL | Sciegen Pharms |
| July 16, 1986 | ANDA070772 | Metronidazole METRONIDAZOLE | Innogenix |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026